Clinical Trial Update: Safety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of alemtuzumab in pediatric intestinal transplantation has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Transplantation in Pediatric Patients
• Liver Transplantation Rejection

Drugs mentioned

• Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: University of Pittsburgh | Conditions: Evidence of Liver Transplantation, Rejection | Phase 2 | Status: COMPLETED | Results posted: 2016-06-20